|
|
Volumn 46, Issue 3, 1996, Pages 134-141
|
|
Systemic treatment of cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKYLATING AGENT;
ALPHA INTERFERON;
ALTRETAMINE;
ANDROGEN;
ANTIMETABOLITE;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIBIOTIC;
AROMATASE INHIBITOR;
ASPARAGINASE;
BETA INTERFERON;
BLEOMYCIN;
CARBOPLATIN;
COLONY STIMULATING FACTOR 1;
CYTARABINE;
DOCETAXEL;
ERYTHROPOIETIN;
GONADORELIN ANTAGONIST;
GRANULOCYTE COLONY STIMULATING FACTOR;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
INTERLEUKIN 1;
INTERLEUKIN 2;
LEVAMISOLE;
PACLITAXEL;
PROCARBAZINE;
RETINOIC ACID;
STEROID;
TUMOR NECROSIS FACTOR;
UNINDEXED DRUG;
VINBLASTINE;
VINCRISTINE;
ADJUVANT CHEMOTHERAPY;
ADRENAL INSUFFICIENCY;
ALOPECIA;
ANOREXIA;
BONE MARROW DEPRESSION;
CANCER;
CANCER CHEMOTHERAPY;
CARDIOTOXICITY;
DIABETES MELLITUS;
FLUID RETENTION;
HEMORRHAGIC CYSTITIS;
HORMONAL THERAPY;
HOT FLUSH;
HUMAN;
HYPERTENSION;
HYPOCALCEMIA;
LEUKOPENIA;
LIVER TOXICITY;
LUNG FIBROSIS;
NAUSEA;
PRIORITY JOURNAL;
REVIEW;
STOMATITIS;
THROMBOCYTOPENIA;
ULCER;
VIRILIZATION;
VOMITING;
|
|
EID: 0030024145
PISSN: 00079235
EISSN: None
Source Type: Journal
DOI: 10.3322/canjclin.46.3.134 Document Type: Review |
|
Times cited : (11)
|
|
References (9)
|
